Human ochratoxin A biomarkers—From exposure to effect

References

• Abid S, Hassen W, Achour A, Skhiri H, Maaroufi K, Ellouz F, Creppy E, Bacha H. (2003). Ochratoxin A and human chronic nephropathy in Tunisia: Is the situation endemic? Hum Exp Toxicol 22:77–84.
   PubMed Web of Science ®Google Scholar
• Abouzied MM, Horvath AD, Podlesny PM, Regina NP, Metodiev VD, Kamenova-Tozeva RM, Niagolova ND, Stein AD, Petropoulos EA, Ganev VS. (2002). Ochratoxin A concentrations in food and feed from a region with Balkan endemic nephropathy. Food Addit Contam 19:755–764.
   PubMed Web of Science ®Google Scholar
• Apostolou E, El-Nezami HS, Ahokas JT, Donohue DC. (1998). The evaluation of ochratoxin A in human milk in Victoria (Australia). Rev Méd Vét 149:709–711.
   Google Scholar
• Aslam M, Beg AE, Blaszkewicz M, Degen GH, Golka K. (2005). Ochratoxin A blood concentration in healthy subjects and bladder cancer cases from Pakistan. Mycot Res 21:164–167.
   PubMedGoogle Scholar
• Assaf H, Betbeder A-M Creppy, EE, Pallardy M, Azouri H. (2004). Ochratoxin A levels in human plasma and foods in Lebanon. Hum Exp Toxicol 23:495–501.
   PubMed Web of Science ®Google Scholar
• Bacha H, Maaroufi K, Achour A, Hamammi M, Ellouz F, Creppy EE. (1993). Ochratoxines et ochratoxicoses humaines en Tunisie. In: Creppy E, Castegnaro M, Dirheimer G, eds. Human Ochratoxicosis and Its Pathologies. Volume 231. Paris: John Libbey Eurotext, 123–127.
   Google Scholar
• Bacha H, Maaroufi K, Ghedira-Chekir L, Abid S, Cherif A, Achour A, Creppy EE. (1999). Mycotoxins and mycotoxicosis in Tunisia: What do we know and what do we need to know? J Toxicol Toxin Rev 18:245–262.
   Google Scholar
• Biasucci G, Calabrese G, Di Giuseppe R, Carrara G, Colombo F, Mandelli B, Maj M, Bertuzzi T, Pietri A, Rossi F. (In press). The presence of ochratoxin A in cord serum and in human milk and its correspondence with maternal dietary habits. Eur J Nutr DOI 10.1007/s00394-010-0130-y.
   Google Scholar
• Biró K, Barna-Vetró I, Pécsi T, Szabó E, Winkler G, Fink-Gremmels J, Solti L. (2003). Evaluation of spermatological parameters in ochratoxin A-challenged boars. Theriogenology 60:199–207.
   PubMedGoogle Scholar
• Breitholtz A, Olsen M, Dahlbäck Å, Hult K. (1991). Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam 8:183–192.
   PubMed Web of Science ®Google Scholar
• Breitholtz-Emanuelsson A, Olsen M, Oskarsson A, Palminger I, Hult K. (1993a). Ochratoxin A in cow’s milk and in human milk with corresponding human blood samples. JAOAC Int 76:842–846.
   Google Scholar
• Breitholtz-Emanuelsson A, Minervini F, Hult K, Visconti A. (1994). Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Nat Toxins 2:366–370.
   PubMedGoogle Scholar
• Breitholtz-Emanuelsson A, Palminger-Hallen I, Wohlin PO, Oskarsson A, Hult K, Olsen M. (1993b). Transfer of ochratoxin A from lactating rats to their offspring: A short-term study. Nat Toxins 1:347–352.
   PubMedGoogle Scholar
• Bunge I, Dirheimer G, Röschenthaler R. (1978). In vivo in vitro inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A. Biochem Biophys Res Commun 83:398–405.
   PubMed Web of Science ®Google Scholar
• Castegnaro M, Canadas D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A. (2006). Balkan endemic nephropathy: Role of ochratoxins A through biomarkers. Mol Nutr Food Res 50:519–529. 1
   PubMed Web of Science ®Google Scholar
• Castegnaro M, Maru V, Maru G, Ruiz-Lopez MD. (1990). High performance liquid chromatography determination of ochratoxin A and its 4R-4-hydroxy metabolite in human urine. Analyst 115:129–131.
   PubMed Web of Science ®Google Scholar
• Conseil Supérieur d’Hygiène Publique de France. (1999). Les mycotoxines dans l’alimentation: évaluation et gestion du risqué. Paris, France: Lavoisier, Tec & Doc.
   Google Scholar
• Coronel MB, Sanchis V, Ramos AJ, Marin S. (2009). Assessment of the exposure to ochratoxin A in the province of Lleida, Spain. Food Chem Toxicol 47:2847–2852.
   PubMed Web of Science ®Google Scholar
• Creppy EE, Baudrimont I, Betbeder A-M. (1995). Prevention of nephrotoxicity of ochratoxin A, a food contaminant. Toxicol Lett 82–83:869–877.
   PubMed Web of Science ®Google Scholar
• Creppy EE, Betbeder AM, Gharbi A, Counord J, Castegnaro M, Bartsch H, Moncharmont P, Fouillet B, Chambon P, Dirheimer G. (1991). Human ochratoxicosis in France. IARC Sci Publ (115):145–151.
   PubMedGoogle Scholar
• Curtui VG, Gareis M. (2001). A simple HPLC method for the determination of the mycotoxins ochratoxin A and B in blood serum of swine. Food Addit Contam 18:635–643.
   PubMed Web of Science ®Google Scholar
• Dahlmann A, Dantzler WH, Silbernagl S, Gekle M. (1998). Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: The nephrotoxin can be reabsorbed in all nephron segments by different mechanisms. J Pharmacol Exp Ther:286:157–162.
   PubMed Web of Science ®Google Scholar
• Dai J, Wright MW, Manderville RA. (2003). Ochratoxin A forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: Implications for C8 reactivity by a phenolic radical. J Am Chem Soc 125:3716–3717.
   PubMed Web of Science ®Google Scholar
• Delatour T, Mally A, Richoz J, Özden S, Dekant W, Ihmels H, Otto D, Gasparutto D, Marin-Kuan M, Schilter B, Cavin C. (2008). Absence of 29-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol Nutr Food Res 52:472–482.
   PubMed Web of Science ®Google Scholar
• Dimitrov P, Tsolova S, Georgieva R, Bozhilova D, Simeonov V, Bonev A, Karmaus W. (2006). Clinical markers in adult offspring of families with and without Balkan endemic nephropathy. Kidney Int 69:723–729.
   PubMed Web of Science ®Google Scholar
• Dinis AMP, Lino CM, Pena AS. (2007). Ochratoxin A in nephropathic patients from two cities of central zone in Portugal. J Pharm Biomed Anal 44:553–557.
   PubMed Web of Science ®Google Scholar
• Doerr JA, Huff WE, Tung HT, Wyatt RD, Hamilton PB. (1974). A survey of T-2 toxin, ochratoxin, and aflatoxin for their effects on the coagulation of blood in young broiler chickens. Poult Sci 53:1728–1734.
   PubMed Web of Science ®Google Scholar
• Domijan AM, Peraica M, Fuchs R, Lucić A, Radić B, Balija M, Bosanac I, Grgičević D. (1999). Ochratoxin A in blood of healthy population in Zagreb. Arh hig Rada Toksikol 50:263–271.
   PubMedGoogle Scholar
• Domijan A-M Peraica, M, Markov K, Fuchs R. (2009). Urine Ochratoxin A and Sphinganine/Sphingosine ratio in residents of the endemic nephropathy area in Croatia. Arh Hig Rada Toksikol 60:387–393.
   PubMedGoogle Scholar
• Dostal A, Jakusova L, Cajdova j, Hudeckova H. (2008). Results of the first studies of occurrence of Ochratoxin A in human milk in Slovakia. Bratisl Lek Listy 109:276–278.
   PubMed Web of Science ®Google Scholar
• Duarte S, Bento J, Pena A, Lino CM, Delerue-Matos C, Oliva-Teles T, Morais S, Correia M, Oliveira MBPP, Alves MR, Pereira JA. (2010). Monitoring of ochratoxin A exposure of the Portuguese population through a nationwide urine survey—Winter 2007. Sci Tot Environ 408:1195–1198.
   PubMed Web of Science ®Google Scholar
• Duarte SC, Bento JMV, Pena A, Lino CM. (2009a). Ochratoxin A exposure assessment of the inhabitants of Lisbon during winter 2007/2008 through bread and urine analysis. Food Addit Contam 26:1411–1420.
   Web of Science ®Google Scholar
• Duarte SC, Pena A, Lino CM. (2009b). Ochratoxin A non-conventional exposure sources—A review. Microchem J 93:115–120.
   Web of Science ®Google Scholar
• EFSA. (2006). Question no. EFSA.Q-2005-154. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food. EFSA.J 365:1–56.
   Google Scholar
• El-Sayed AA, Neamat-Allah AA, Soher EA. (2000). Situation of mycotoxins in milk, dairy products and human milk in Egypt. Mycot Res 16:91–100.
   PubMedGoogle Scholar
• EI-Sayed AA, Soher EA, Neamat-Allah AA. (2002). Human exposure to mycotoxins in Egypt. Mycot Res 18:23–30.
   PubMedGoogle Scholar
• Erkekoğlu P, Sabuncuoğlu S, Aydın S, Şahin G, Giray B. (2010). Determination of seasonal variations in serum ochratoxin A levels in healthy population living in some regions of Turkey by enzyme-linked immunosorbent assay. Toxicon 55:507–513.
   PubMed Web of Science ®Google Scholar
• Faucet V, Pfohl-Leszkowicz A, Dai J, Castegnaro M, Manderville RA (2004). Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem Res Toxicol 17:1289–1296.
   PubMed Web of Science ®Google Scholar
• Fazecas B, Tar A, Kovacs M. (2005). Ochratoxin a content of urine samples of healthy humans in Hungary. Acta Vet Hung 53:35–44.
   PubMedGoogle Scholar
• Fenske M, Fink-Gremmels J. (1990). Effects of fungal metabolites on testosterone secretion in vitro. Arch Toxicol 64:72–75.
   PubMed Web of Science ®Google Scholar
• Ferrufino-Guardia EV, Tangni EK, Larondelle Y, Ponchaut S. (2000). Transfer of ochratoxin A during lactation: Exposure of suckling via the milk of rabbit does fed a naturally contaminated Feed. Food Addit Contam 17:167–175.
   PubMed Web of Science ®Google Scholar
• Filali A, Betbeder AM, Baudrimont I, Benayada A, Soulaymani R, Creppy EE. (2002). Ochratoxin A in human plasma in Morocco: A preliminary survey. Hum Exp Toxicol 21:241–245.
   PubMed Web of Science ®Google Scholar
• Fink-Gremmels J. (2008). Mycotoxins in cattle feeds and carry-over to dairy milk: A review. Food Addit Contam Part A 25:172–180.
   Web of Science ®Google Scholar
• Galtier P, Baradat C, Alvinere M. (1977). Etude de l’élimination d’ochratoxine A par le lait chez la lapine. Ann Rech Vét 7:97–98.
   Google Scholar
• Galvano F, Pietri A, Bertuzzi T, Gagliardi L, Ciotti S, Luisi S, Bognanno M, Fauci1 L Iacopino, AM, Nigro F, Volti GL, Vanella L, Giammanco G, Tina GL, Gazzolo D. (2008). Maternal dietary habits and mycotoxin occurrence in human mature milk. Mol Nutr Food Res 52:496–501.
   PubMed Web of Science ®Google Scholar
• García-Fonseca S, Ballesteros-Gómez A, Rubio S, Pérez-Bendito D. (2008). Coacervative extraction of Ochratoxin A in wines prior to liquid chromatography/fluorescence determination. Anal Chim Acta 617:3–10
   PubMed Web of Science ®Google Scholar
• Gautier J-C Richoz, J, Welti DH, Markovic J, Gremaud E, Guengerich FP, Turesky RJ. (2001). Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes. Chem Res Toxicol 14:34–45.
   PubMedGoogle Scholar
• Gekle M, Sauvant C, Schwerdt G. (2005). Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells. Mol Nutr Food Res 49:118–130.
   PubMed Web of Science ®Google Scholar
• Ghali R, Hmaissia-Khlifa K, Mezigh CH, Ghorbel H, Maaroufi K, Maschgoul S, Hedilli A. (2008). HPLC Determination of ochratoxin A in a low volume of human blood serum. Anal Lett 41:757–766.
   Web of Science ®Google Scholar
• Gharbi A, Trillon O, Betbeder AM, Counord J, Gauret MF, Pfohl-Leszkowicz A, Dirheimer G, Creppy EE. (1993). Some effects of ochratoxin A, a mycotoxin contaminating feeds and food, on rat testis. Toxicology 83:9–18.
   PubMedGoogle Scholar
• Gilbert J, Brereton P, MacDonald S. (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam 18:1088–1093.
   PubMed Web of Science ®Google Scholar
• Grosse Y, Baudrimont I, Castegnaro M, Creppy EE, Dirheimer G, Pfohl-Leskowicz A. (1995). Ochratoxin A metabolites and DNA-adducts formation in monkey kidney cell. Chem Biol Interact 95:175–187.
   PubMed Web of Science ®Google Scholar
• Grosse Y, Chekir-Ghedira L Huc A, Obrecht-Pflumio S, Dirheimer G, Bacha H, Pfohl-Leskowicz A. (1997). Retinol ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxin ochartoxin A and zearalenone. Cancer Lett 114:225–229.
   PubMed Web of Science ®Google Scholar
• Grosso F, Saïd S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S. (2003). New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 41:1133–1140.
   PubMed Web of Science ®Google Scholar
• Gross-Steinmeyer K, Weymann J, Hege HG, Metzler M. (2002). Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin a in cultured rat and human primary hepatocytes. J Agric Food Chem 50:938–945.
   PubMed Web of Science ®Google Scholar
• Gürbay A, Girgin G, Sabuncuoğlu SA, Şahin G, Yurdakök M, Yiğit Ş, Tekinalp G. (2009). Ochratoxin A: Is it present in human breast milk samples obtained mothers from Ankara, Turkey. In: Abstracts of the 46th Congress of the European Societies of Toxicology; 13–16 September 2009; Dresden, Germany. Toxicol Lett 189(Supp 1):S57–S273.
   PubMedGoogle Scholar
• Gupta M, Bandopadhyay S, Paul B, Majumder SK. (1979). Hematological changes produced in mice by ochratoxin A. Toxicology 14:95–98.
   PubMedGoogle Scholar
• Hagelberg S, Hult K, Fuchs R. (1989). Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J Appl Toxicol 9:91–96.
   PubMed Web of Science ®Google Scholar
• Hall PW, Vasiljević M. (1973). Beta2-microglobulin excretion as an index of renal tubular disorders with special reference to endemic Balkan nephropathy. J Lab Clin Med 81:897–904.
   PubMed Web of Science ®Google Scholar
• Hassan AM, Sheashaa HA, Fattah MFA, Ibrahim AZ, Gaber OA, Sobh MA. (2006). Study of ochratoxin A as an environmental risk that causes renal injury in breast-fed Egyptian infants. Pediatr Nephrol 21:102–105.
   PubMed Web of Science ®Google Scholar
• Hassen W, Abid S, Achour A, Creppy E, Bacha H. (2004). Ochratoxin A and β2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the Centre of Tunisia: A hot spot of Ochratoxin A exposure. Toxicology 199:185–193.
   PubMed Web of Science ®Google Scholar
• Höhler D, Sudekum KH, Wolffram S, Frohlich AA, Marquardt RR. (1999). Metabolism and excretion of ochratoxin A fed to sheep. J Anim Sci 77:1217–1223.
   PubMed Web of Science ®Google Scholar
• Hult K, Plestina R, Habazin-Novak V, Radic B, Ceovic S. (1982). Ochratoxin A in human blood and Balkan endemic nephropathy. Arch Toxicol 51:313–321.
   Web of Science ®Google Scholar
• IARC. (1993). Some Naturally Occurring Substances, Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. Monograph no. 56. Lyon, France: IARC.
   Google Scholar
• Iavicoli I, Brera C, Carelli G, Caputi R, Marinaccio A, Miraglia M. (2002). External and internal dose in subjects occupationally exposed to ochratoxin A. Int Arch Occup Environ Health 75:381–386.
   PubMed Web of Science ®Google Scholar
• JECFA. (1991). Evaluation of Certain Food Additives and Contaminants. Thirty-seventh report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series, No. 806. Geneva: Joint FAO/WHO Expert Committee on Food Additives
   Google Scholar
• JECFA. (2001). Safety Evaluation of Certain Mycotoxins in Food. WHO Food Additives Series 47; FAO Food and Nutrition Paper 74. Available at: http://www.inchem.org/documents/jecfa/jecmono/v47je01.htm. Accessed 10 August 2008.
   Google Scholar
• JECFA. (2007). Safety Evaluations of Specific Mycotoxins: Ochratoxin A. Prepared by the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives, 6–15 February, Geneva.
   Google Scholar
• JECFA. (2008). Safety Evaluation of Certain Mycotoxins in Food. WHO Food Additives Series 59. Available at: http://whqlibdoc.who.int/publications/2008/978924 1660594_eng.pdf. Accessed 18 November 2009.
   Google Scholar
• Jennings-Gee JE, Tozlovanu M, Manderville R, Miller MS, Pfohl-Leszkowicz A, Schwartz GG. (2010). Ochratoxin A: In utero exposure in mice induces adducts in testicular DNA. Toxins 2:1428–1444.
   PubMedGoogle Scholar
• Jiménez AM, Lopez de Cerain˜ A, Gonzalez-Peñas E, Bello J, Betbeder AM, Creppy EE. (1998). Exposure to ochratoxin A in Europe: Comparison with a region of northern Spain. Toxin Rev 17:479–491.
   Web of Science ®Google Scholar
• Jonsyn FE, Maxwell SM, Hendrickse RG. (1995). Ochratoxin A and aflatoxins in breast milk samples from Sierra Leone. Mycopathology 131:121–126.
   PubMed Web of Science ®Google Scholar
• Jonsyn FE. (1999). Intake of aflatoxins and ochratoxins by infants in Sierra Leone: Possible effects on the general health of these children. J Nutr Environ Med 9:15–22.
   Google Scholar
• Jonsyn-Ellis FE. (2000). Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girls. Mycopathology 152:35–40.
   Web of Science ®Google Scholar
• Jonsyn-Ellis FE. (2007). Aflatoxins and ochratoxins in serum samples of school children. J Nutr Environ Med 16:52–58.
   Google Scholar
• Jørgensen K, Petersen A. (2002). Content of ochratoxin A in paired kidney and meat samples from healthy Danish slaughter pigs. Food Addit Contam 19:562–567.
   PubMed Web of Science ®Google Scholar
• Karima H-K Ridha, G, Zied A, Chekib M, Salem M, Abderrazek H. (2010). Estimation of Ochratoxin A in human blood of healthy Tunisian population. Exp Toxicol Pathol 62:539–542.
   PubMedGoogle Scholar
• Khalef A, Zidane C, Charef A, Gharbi A, Tadjerouna M, Betbeder AM, Creppy EE. (1993). Ochratoxicoses humaines en Algérie. In: Creppy E, Castegnaro M, Dirheimer G, eds. Human Ochratoxicosis and Its Pathologies. Volume 231. Paris: John Libbey Eurotext, 123–127.
   Google Scholar
• Kovács F, Sándor G, Ványi A, Domány S, Zomborszky-Kovács M. (1995). Detection of ochratoxin A in human blood and colostrum. Acta Vet Hung 43:393–400
   PubMed Web of Science ®Google Scholar
• Krogh P, Hald B, Plestina R, Ceović S. (1977). Balkan (endemic) nephropathy and foodborne Ochratoxin A: Preliminary results of a survey of foodstuffs. Acta Pathol Microbiol Scand B 85, 238–240.
   PubMedGoogle Scholar
• Krogh P. (1977). Ochratoxin A residues in tissues of slaughter pigs with nephropathy. Nord Vet Med 29:402–405.
   PubMedGoogle Scholar
• Kuiper-Goodman T, Hilts C, Billiard SM, Kiparissis Y, Richard IDK, Hayward S. (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market Economy. Food Addit Contam 27, 212–240.
   PubMed Web of Science ®Google Scholar
• Kuiper-Goodman T. (1990). Uncertainties in the risk assessment of three mycotoxins: Aflatoxin, ochratoxin, and zearalenone. Can J Physiol Pharmacol 68:1017–1024.
   PubMed Web of Science ®Google Scholar
• Kyrtopoulos SA. (2006). Biomarkers in environmental carcinogenesis research: Striving for a new momentum. Toxicol Lett 162:3–15.
   PubMed Web of Science ®Google Scholar
• Larsen JC. (1995). Levels of pollutants and their metabolites: Exposures to organic substances. Toxicology 101:11–27.
   PubMed Web of Science ®Google Scholar
• Li S, Marquardt RR, Frohlich AA. (2000). Identification of ochratoxins and some of their metabolites in bile and urine of rats. Food Chem Toxicol 38:141–152.
   PubMed Web of Science ®Google Scholar
• Lino CM, Baeta ML, Henri M, Dinis AMP, Pena AS, Silveira MIN. (2008). Levels of ochratoxin A in serum from urban and rural Portuguese populations and estimation of exposure degree. Food Chem Toxicol 46:879–885.
   PubMed Web of Science ®Google Scholar
• Maaroufi K, Achour A, Hamammi M, El May M, Betbeder AM, Ellouz F, Creppy EE, Bacha H. (1995). Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol 14:609–615.
   PubMed Web of Science ®Google Scholar
• MAFF—Ministry of Agriculture, Fisheries and Food. (April 1999). A Survey of Human Exposure to Ochratoxin A. Food Surveillance Information Sheet, number 172. London, United Kingdom.
   Google Scholar
• Mally A, Dekant W. (2009). Mycotoxins and the kidney: Modes of action for renal tumor formation by ochratoxin A in rodents. Mol Nutr Food Res 53:467–478.
   PubMed Web of Science ®Google Scholar
• Mally A, Hard GC, Dekant W. (2007). Ochratoxin A as a potential etiologic factor in endemic nephropathy: Lessons learned from toxicity studies in rats. Food Chem Toxicol 45:254–2260.
   Google Scholar
• Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H, Völkel W, Dekant W. (2004). Ochratoxin A: Lack of formation of covalent DNA adducts. Chem Res Toxicol 17:234–242.
   PubMed Web of Science ®Google Scholar
• Manderville RA, Pfohl-Leszkowicz A. (2008). Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycot J 1:357–367.
   Web of Science ®Google Scholar
• Manique R, Pena A, Lino CM, Moltó JC, Mañez J. (2008). OchratoxinA in themorning and afternoon portions of urine from Coimbra and Valencia populations. Toxicon 51:1281–1287.
   PubMed Web of Science ®Google Scholar
• Mantle PG, Faucet-Marquis V, Manderville RA, Sciqualli B, Pfohl-Leszkowicz A. (2010). Structures of covalent adducts between DNA and ochratoxin A: A new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 23:89–98.
   PubMed Web of Science ®Google Scholar
• Micco C, Ambruzzi A, Miraglia M, Brera C, Onori R, Benelli L. (1991). Contamination of human milk with ochratoxin A. In: Castegnaro PR, Plestina R, Dirheimer M, Chernozemsky G, Bartsch IN, eds. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. Lyon, France: IARC, 105–108.
   Google Scholar
• Micco C, Miraglia M, Brera C, Corneli S, Ambruzzi A. (1995). Evaluation of ochratoxin A level in human milk in Italy. Food Addit Contam Part A 12:351–354.
   PubMed Web of Science ®Google Scholar
• Miraglia M, Brera C, Colatosti M. (1996). Application of Biomarkers to assessment of risk to human health from exposure to mycotoxins. Microchem J 54:472–477.
   Web of Science ®Google Scholar
• Miraglia M, Brera C. (2002). Assessment of dietary intake of ochratoxin A by the population of EU member states. SCOOP/2002. Task 3.2.7. Brussels: European Union.
   Google Scholar
• Mosesso P, Cinelli S, Piñerro J, Bellacima R, Pepe G. (2008). In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity. Chem Res Toxicol 21:1235–1243.
   PubMed Web of Science ®Google Scholar
• Muñoz K, Blaszkewicz M, Degen G. (In press). Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin. J Chromatogr B 2010.878.2623–2629.
   PubMed Web of Science ®Google Scholar
• Muñoz K, Vega M, Rios G, Muñoz S, Madariaga R. (2006). Preliminary study of Ochratoxin A in human plasma in agricultural zones of Chile and its relation to food consumption. Food Chem Toxicol 44:1884–1889.
   PubMed Web of Science ®Google Scholar
• Navas SA, Sabino M, Rodriguez-Amaya DB. (2005). Aflatoxin M1 and ochratoxin A in a human milk bank in the city of São Paulo, Brazil. Food Addit Contam 22:457–462.
   PubMed Web of Science ®Google Scholar
• Nikolov IG, Chernozemsky IN, Petkova-Bocharova T, Vrabcheva T, Stojchev I, Bankov B, Castegnaro M, Pfohl-Leszkowicz A, Dragacci S, Day N, Gill C, Useleber E, Dietrich R, Martlbauer E. (2002). Review of the cooperative studies of the national oncological centre in Bulgaria on Balkan endemic nephropathy and associated urinary tract tumours (1991–2001). Facta Univ Ser Med Biol 9:119–122.
   Google Scholar
• Nordic Working Group on Food Toxicology and Risk Evaluation. (1991). Health Evaluation of ochratoxin A in food products. Nordic Seminar and Work Report 545. Copenhagen, Denmark: Nordic Council of Ministers, 1–26.
   Google Scholar
• Obrecht-Pflumio S, Dirheimer G. (2000). In vitro DNA and dGMP adducts formation caused by ochratoxin A. Chem Biol Interact 127:29–44.
   PubMed Web of Science ®Google Scholar
• Ostry V, Malir F, Roubal T, Skarkova J, Ruprich J, Cerna M, Creppy EE. (2005). Monitoring of mycotoxin biomarkers in the Czech Republic. Mycot Res 21:49–52.
   PubMedGoogle Scholar
• Özçelik N, Koşar A, Soysal D. (2001). Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol Lett 121:9–13.
   PubMed Web of Science ®Google Scholar
• Pacin AM, Ciancio Bovier EV, Motta E, Resnik SL, Villa D, Olsen M. (2008). Survey of Argentinean human plasma for ochratoxin A. Food Addit Contam Part A 25:635–641.
   Web of Science ®Google Scholar
• Palli D, Miraglia M, Saieva C, Masala G, Cava E, Colatosti M, Corsi AM, Russo A, Brera C. (1999). Serum levels of Ochratoxin A in healthy adults in Tuscany: Correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomark Prevent 8:265–269.
   PubMed Web of Science ®Google Scholar
• Pascale M, Visconti A. (2000). Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high-performance liquid chromatography. Mycopathology 152:91–95.
   Web of Science ®Google Scholar
• Pena A, Seifrtová M, Lino CM, Silveira MIN, Solich P. (2006). Estimation of ochratoxin A in Portuguese population: New data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection. Food Chem Toxicol 4:1449–1454.
   Google Scholar
• Peraica M, Domijan A-M Fuchs, R, Lucić A, Radić B. (1999). The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett 110:105–112.
   PubMed Web of Science ®Google Scholar
• Peraica M, Domijan AM, Matasin M, Lucić A, Radić B, Delas F, Horvat M, Bosanac I, Balija M, Grgičević D. (2001). Variations of ochratoxin A concentrations in the blood of healthy populations in some Croatian cities. Arch Toxicol 75:410–414.
   PubMed Web of Science ®Google Scholar
• Petkova-Bocharova T, Castegnaro M. (1985). Ochratoxin A contamination of cereal in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit Contam 2:267–270.
   PubMed Web of Science ®Google Scholar
• Petkova-Bocharova T, Castegnaro M, Pfohl-Leszkowicz A, Garren L, Grosso F, Nikolov I, Vrabcheva T, Dragacci S, Chernozemsky IN. (2003). Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan endemic nephropathy: A one month follow up study. Facta Univ Ser Med Biol 10:62–68.
   Google Scholar
• Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. (1988). Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit Contam 5:299–301.
   PubMedGoogle Scholar
• Pfohl-Leszkowicz A, Grosse Y, Kane A, Creppy EE, Dirheimer G. (1993). Differential DNA adduct formation and disappearance in the mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat Res 289:265–273.
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A. (2009). Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 60:465–483.
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Manderville RA. (2007). Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51:61–99.
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. (2002). Balkan endemic nephropathy and associated urinary tract tumours: A review on aetiological causes and the potential role of mycotoxins. Food Addit Contam 19:282–302.
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Pinelli E, Bartsch H, Mohr U, Castegnaro M. (1998). Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol carcinog 23:76–85.
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. (2007). New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res 51:1131–1146.
   PubMed Web of Science ®Google Scholar
• Poirier MC, Santella RM, Weston A. (2000). Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21:353–359.
   PubMed Web of Science ®Google Scholar
• Postupolski J, Karłowski K, Kubik P. (2006). Ochratoxin a in maternal and foetal blood and in maternal milk. Rocz Panstw Zakl Hig 57:23–30.
   PubMedGoogle Scholar
• Radić B, Fuchs R, Peraica M, Lucić A. (1997). Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol Lett 91:105–109.
   PubMed Web of Science ®Google Scholar
• Rizzo A, Eskola M, Atroshi F. (2002). Ochratoxin A in cereals, foodstuffs and human plasma. Eur J Plant Pathol 108:631–637.
   Web of Science ®Google Scholar
• Roth A, Chakor K, Creepy EE, Kane A, Roschenthaler R, Dirheimer G. (1988). Evidence for an enterohepatic circulation of ochratoxin A in mice. Toxicology 48:293–308.
   PubMed Web of Science ®Google Scholar
• Sabolić I, Asif AR, Budach WE, Wanke C, Bahn A, Burckhardt G. (2007). Gender differences in kidney function. Pflugers Arch Eur J Physiol 455:397–429.
   PubMed Web of Science ®Google Scholar
• Sangare-Tigori B, Moukha S, Kouadio JH, Dano DS, Betbeder A-M Achour, A, Creppy EE. (2006). Ochratoxin A in human blood in Abidjan, Côte d’Ivoire. Toxicon 47:894–900.
   PubMed Web of Science ®Google Scholar
• Sauvant C, Holzinger H, Gekle M. (2005). Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2. J Pharmacol Exp Ther 313:234–241.
   PubMed Web of Science ®Google Scholar
• SCF-Scientific Committee on Food. (1998). EC report, Opinion on ochratoxin A, expressed on 17 September 1998. Health and Consumers Directorate-General. Brussels, Belgium.
   Google Scholar
• Schlatter C, Studer RJ, Rasonyi T. (1996). Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam 43–44.
   PubMedGoogle Scholar
• Schwartz GG. (2002). Hypothesis: Does ochratoxin A cause testicular cancer? Cancer Causes Cont 13:91–100.
   PubMed Web of Science ®Google Scholar
• Schwerdt G, Freudinger R, Silbernagl S, Gekle M. (1999). Ochratoxin A-binding proteins in rat organs and plasma and different cell lines of the kidney. Toxicology 135:1–10.
   PubMed Web of Science ®Google Scholar
• Schwerdt G, Holzinger H, Königs M, Humpf H-U, Gekle M. (2009). Effect of ochratoxin A on cell survival and collagen homeostasis in human mesangial cells in primary culture. Food Chem Toxicol 47:209–213.
   PubMedGoogle Scholar
• Scott PM. (2005). Biomarkers of human exposure to ochratoxin A. Food Addit Contam 22(Supp 1):99–107.
   PubMedGoogle Scholar
• Shephard GS, Van der Westhuizen L, Sewram V. (2007). Biomarkers of exposure to fumonisin mycotoxins: A review. Food Addit Contam 24:1196–1201.
   PubMed Web of Science ®Google Scholar
• Skaug MA, Helland I, Solvoll K, Saugstad OD. (2001). Presence of ochratoxin A in human milk in relation to dietary intake. Food Addit Contam 18:321–327.
   PubMed Web of Science ®Google Scholar
• Skaug MA, Størmer FC, Saugstad OD. (1998). Ochratoxin A: A naturally occurring mycotoxin found in human milk samples from Norway. Acta Pædiatr 87:1275–1278.
   PubMed Web of Science ®Google Scholar
• Solti L, Pécsi T, Barna-Vetró I, Szász F, Biró K, Szabó E. (1999). Analysis of serum and seminal plasma after feeding ochratoxin A with breeding boars. Anim Reprod Sci 56:123–132.
   PubMedGoogle Scholar
• Stefanovic V, Cukuranovic R, Mitic-Zlatkovic M, Hall PW. (2002). Increased urinary albumin excretion in children from families with Balkan nephropathy. Pediatr Nephrol 17:913–916.
   PubMed Web of Science ®Google Scholar
• Stefanovic V, Mitic-Zlatkovic M, Cukuranovic R, Miljkovic P, Pavlovic NM, Vlahovic P. (1991). β2-microglobulin in patients with Balkan nephropathy and in healthy members of their families. Kidney Int 40:21–26.
   PubMedGoogle Scholar
• Stefanovic V, Mitic-Zlatkovic M, Cukuranovic R, Vlahovic P. (2003). Increased urinary protein excretion in children from families with Balkan endemic nephropathy. Nephron Clin Pract 95:116–120.
   Google Scholar
• Stoev SD. (2010). Studies on carcinogenic and toxic effects of ochratoxin A in chicks. Toxins 2:649–664.
   PubMed Web of Science ®Google Scholar
• Stoev SD, Vitanov S, Anguelov G, Petkova-Bocharova T, Creppy EE. (2001). Experimental mycotoxic nephropathy in pigs provoked by a diet containing ochratoxin A and penicillic acid. Vet Res Com 25:205–223.
   PubMed Web of Science ®Google Scholar
• Stojkovic R, Hult S, Gamulin R, Plestina R. (1984). High affinity binding of ochratoxin A to plasma constituents. Biochem Int 9:33–38.
   PubMedGoogle Scholar
• Studer-Rohr I, Schlatter J, Dietrich DR. (2000). Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch Toxicol 74:499–510.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Satoh T, Yamazaki M. (1975). Effect of ochratoxin A on carbohydrate metabolism in rat liver. Toxicol Appl Pharmacol 32:116–122.
   PubMed Web of Science ®Google Scholar
• Thuvander A, Paulsen JE, Axberg K, Johansson N, Vidnes A, Enghardt-Barbieri H, Trygg K, Lund-Larsen K, Jahrl S, Widenfalk A, Bosnes V, Alexander J, Hult K, Olsen M. (2001). Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 39:1145–1151.
   PubMed Web of Science ®Google Scholar
• Timbrell JA. (1998). Biomarkers in toxicology. Toxicology 129:1–12.
   PubMed Web of Science ®Google Scholar
• Tozlovanu M, Faucet-Marquis V, Pfohl-Leszkowicz A, Manderville RA (2006). Genotoxicity of the hydroquinone metabolite of ochratoxin A: Structure-activity relationships for covalent DNA adduction. Chem Res Toxicol 19:1241–1247.
   PubMed Web of Science ®Google Scholar
• Turconi G, Guarcello M, Livieri C, Comizzoli S, Maccarini L, Castellazzi AM, Pietri A, Piva G, Roggi C. (2004). Evaluation of xenobiotics in human milk and ingestion by the newborn—An epidemiological survey in Lombardy (Northern Italy). Eur J Nutr 43:191–197.
   PubMed Web of Science ®Google Scholar
• Ueno Y, Maki S, Lin J, Furuya M, Sugiura Y, Kawamura O. (1998). A 4-year study of plasma ochratoxin a in a selected population in Tokyo by immunoassay and immunoaffinity column-linked HPLC. Food Chem Toxicol 36:445–449.
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Ferguson MA, Bonventre JV. (2008). Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48:463–493.
   PubMed Web of Science ®Google Scholar
• Valenta H. (1998). Chromatographic methods for the determination of ochratoxin A in animal and human tissues and fluids. J Chromatogr A 815:75–92.
   PubMed Web of Science ®Google Scholar
• Van der Merwe KJ, Steyn PS, Fourie L, Scott DB, Theron JJ. (1965). Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205:1112–1113.
   PubMed Web of Science ®Google Scholar
• Vatinno R, Aresta A, Zambonin CG, Palmisano F. (2007). Determination of ochratoxin A in human urine by solid-phase microextraction coupled with liquid chromatography-fluorescence detection. J Pharm Biomed Anal 44:1014–1018.
   PubMedGoogle Scholar
• Wafa EW, Yahya RS, Sobh MA, Eraky I, El-Baz M, El-Gayar HAM, Betbeder AM, Creppy EE. (1998). Human ochratoxicosis and nephropathy in Egypt: A preliminary study. Hum Exp Toxicol 17:124–129.
   PubMed Web of Science ®Google Scholar
• Zimmerli B, Dick R. (1995). Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: Methodology and Swiss data. J Chromatogr B Biomed Appl 666:85–99.
   PubMed Web of Science ®Google Scholar